Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Eur J Clin Pharmacol ; 74(6): 775-783, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29480324

RESUMEN

PURPOSE: The aim of the present study is to investigate a possible role of a single dose of (-)-epigallocatechin gallate (EGCG), the major catechin in green tea, for the pharmacokinetic interaction between green tea and nadolol in humans. METHODS: In a randomized three-phase crossover study, 13 healthy volunteers received single doses of 30 mg nadolol orally with water (control), or an aqueous solution of EGCG-concentrated green tea extract (GTE) at low or high dose. Plasma concentrations and urinary excretion of nadolol were determined up to 48 h. In addition, blood pressure and pulse rate were monitored. In vitro transport kinetic experiments were performed using human embryonic kidney 293 cells stably expressing organic anion transporting polypeptide (OATP)1A2 to evaluate the inhibitory effect of EGCG on OATP1A2-mediated substrate transport. RESULTS: Single coadministration of low and high dose GTE significantly reduced the plasma concentrations of nadolol. The geometric mean ratios with 90% CI for area under the plasma concentration-time curves from 0 to infinity of nadolol were 0.72 (0.56-0.87) for the low and 0.60 (0.51-0.69) for the high dose. There were no significant differences in Tmax, elimination half-life, and renal clearance between GTE and water phases. No significant changes were observed for blood pressure and pulse rate between phases. EGCG competitively inhibited OATP1A2-mediated uptake of sulphobromophthalein and nadolol with Ki values of 21.6 and 19.4 µM, respectively. CONCLUSIONS: EGCG is suggested to be a key contributor to the interaction of green tea with nadolol. Moreover, even a single coadministration of green tea may significantly affect nadolol pharmacokinetics.


Asunto(s)
Antagonistas Adrenérgicos beta/farmacocinética , Antioxidantes/farmacología , Camellia sinensis , Catequina/análogos & derivados , Nadolol/farmacocinética , Extractos Vegetales/farmacología , Antagonistas Adrenérgicos beta/sangre , Antagonistas Adrenérgicos beta/orina , Adulto , Antioxidantes/análisis , Proteínas Sanguíneas/metabolismo , Catequina/análisis , Catequina/farmacología , Estudios Cruzados , Interacciones Farmacológicas , Femenino , Células HEK293 , Voluntarios Sanos , Humanos , Masculino , Persona de Mediana Edad , Nadolol/sangre , Nadolol/orina , Transportadores de Anión Orgánico , Extractos Vegetales/análisis , Unión Proteica , Adulto Joven
2.
Eur J Clin Pharmacol ; 74(5): 601-609, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29368187

RESUMEN

PURPOSE: The objective of this study is to assess the effects of green tea and its major catechin component, (-)-epigallocatechin gallate (EGCG), on CYP2C9-mediated substrate metabolism in vitro, and the pharmacokinetics of fluvastatin in healthy volunteers. METHODS: The metabolism of diclofenac and fluvastatin in human recombinant CYP2C9 was investigated in the presence of EGCG. In a randomized three-phase crossover study, 11 healthy volunteers ingested a single 20-mg dose of fluvastatin with green tea extract (GTE), containing 150 mg of EGCG, along with water (300 mL), brewed green tea (300 mL), or water (300 mL) after overnight fasting. Plasma concentrations of fluvastatin and EGCG were measured by ultra-performance liquid chromatography with fluorescence detection and a single mass spectrometer. RESULTS: EGCG inhibited diclofenac 4'-hydroxylation and fluvastatin degradation with IC50 of 2.23 and 48.04 µM, respectively. Brewed green tea used in the clinical study also dose-dependently inhibited the metabolism of diclofenac and fluvastatin in vitro. However, no significant effects of GTE and brewed green tea were observed in plasma concentrations of fluvastatin. The geometric mean ratios with 90% CI for area under the plasma concentration-time curve (AUC0-∞) of fluvastatin were 0.993 (0.963-1.024, vs. brewed green tea) and 0.977 (0.935-1.020, vs. GTE). CONCLUSIONS: Although in vitro studies indicated that EGCG and brewed green tea produce significant inhibitory effects on CYP2C9 activity, the concomitant administration of green tea and fluvastatin in healthy volunteers did not influence the pharmacokinetics of fluvastatin.


Asunto(s)
Catequina/análogos & derivados , Citocromo P-450 CYP2C9/metabolismo , Ácidos Grasos Monoinsaturados/farmacocinética , Inhibidores de Hidroximetilglutaril-CoA Reductasas/farmacocinética , Indoles/farmacocinética , , Adulto , Antiinflamatorios no Esteroideos/farmacocinética , Catequina/análisis , Catequina/sangre , Catequina/farmacocinética , Catequina/farmacología , Estudios Cruzados , Diclofenaco/farmacocinética , Ácidos Grasos Monoinsaturados/sangre , Femenino , Fluvastatina , Interacciones Alimento-Droga , Voluntarios Sanos , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/sangre , Indoles/sangre , Masculino , Té/química , Adulto Joven
3.
Can J Physiol Pharmacol ; 94(7): 728-33, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27128150

RESUMEN

Prevention and treatment of Alzheimer disease are urgent problems for elderly people in developed countries. We previously reported that nobiletin, a poly-methoxylated flavone from the citrus peel, improved the symptoms in various types of animal models of memory loss and activated the cAMP responsive element (CRE)-dependent transcription in PC12 cells. Nobiletin activated the cAMP/PKA/MEK/Erk/MAPK signaling pathway without using the TrkA signaling activated by nerve growth factor (NGF). Here, we examined the effect of combination of nobiletin and NGF on the CRE-dependent transcription in PC12 cells. Although NGF alone had little effect on the CRE-dependent transcription, NGF markedly enhanced the CRE-dependent transcription induced by nobiletin. The NGF-induced enhancement was neutralized by a TrkA antagonist, K252a. This effect of NGF was effective on the early signaling event elicited by nobiletin. These results suggested that there was crosstalk between NGF and nobiletin signaling in activating the CRE-dependent transcription in PC12 cells.


Asunto(s)
Modulador del Elemento de Respuesta al AMP Cíclico/metabolismo , Flavonas/farmacología , Factor de Crecimiento Nervioso/farmacología , Extractos Vegetales/farmacología , Transcripción Genética/fisiología , Animales , Modulador del Elemento de Respuesta al AMP Cíclico/genética , Sinergismo Farmacológico , Flavonas/aislamiento & purificación , Células PC12 , Extractos Vegetales/aislamiento & purificación , Ratas , Transcripción Genética/efectos de los fármacos
4.
J Urol ; 195(3): 780-7, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26518110

RESUMEN

PURPOSE: Bladder ischemia and oxidative stress contribute to the pathogenesis of bladder dysfunction caused by bladder outlet obstruction. H2 reportedly acts as an effective antioxidant. We investigated whether oral ingestion of H2 water would have a beneficial effect on bladder function in a rat model of bladder outlet obstruction. MATERIALS AND METHODS: H2 water was made by dissolving H2 gas in ordinary drinking water using a hydrogen water producing apparatus. The bladder outlet obstruction model was surgically induced in male rats. Rats with obstruction were fed H2 water or ordinary drinking water. On week 4 postoperatively cystometry was performed. Oxidative stress markers and the bladder nerve growth factor level were determined. Bladder tissues were processed for pharmacological studies and histological analysis. RESULTS: The micturition interval and micturition volume significantly decreased in obstructed rats given ordinary drinking water. These decreases were significantly suppressed by oral ingestion of H2 water. Increased post-void residual volume in obstructed rats was significantly reduced by H2 water. Obstruction led to a significant increase in bladder weight, oxidative stress markers and nerve growth factor. H2 water significantly suppressed these increases without affecting bladder weight. There was no significant difference in histological findings between rats with bladder obstruction given H2 water and ordinary drinking water. Decreased responses of detrusor muscle strips from obstructed bladders to KCl, carbachol and electrical field stimulation were reversed by H2 water ingestion. CONCLUSIONS: Results suggest that H2 water could ameliorate bladder dysfunction secondary to bladder outlet obstruction by attenuating oxidative stress.


Asunto(s)
Hidrógeno/uso terapéutico , Obstrucción del Cuello de la Vejiga Urinaria/complicaciones , Vejiga Urinaria Hiperactiva/etiología , Vejiga Urinaria Hiperactiva/prevención & control , Agua , Animales , Modelos Animales de Enfermedad , Masculino , Estrés Oxidativo , Ratas , Ratas Sprague-Dawley , Obstrucción del Cuello de la Vejiga Urinaria/metabolismo
5.
Fukushima J Med Sci ; 60(1): 22-30, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24670676

RESUMEN

Shakuyakukanzoto (shao-yao-gan-cao-tang) is a commonly used Chinese traditional herbal medicine for the treatment of acute pain with muscle cramp. However, its mechanism of action is unclear. We previously reported that a low concentration of Kanzo (licorice) and isoliquiritigenin, a component of licorice, inhibited the potassium (K(+)) current in H9c2 cells. Therefore, in the present study, we examined the effects of Shakuyakukanzoto, Shakuyaku or Kanzo on the K(+) current (IKur) in H9c2 cells. Shakuyakukanzoto inhibited IKur in a concentration-dependent manner. The half-maximal concentration of Shakuyakukanzoto was approximately 1.3 mg/mL and the Hill coefficient was 1.2. The order of potency of inhibiting IKur was Kanzo>Shakuyakukanzoto>Shakuyaku. Glycyrrhizin, a major component of licorice, had no inhibitory effect on IKur. A small interfering RNA experiment indicated that IKur was most likely to be Kv2.1 in H9c2 cells. Our results suggest that Shakuyakukanzoto may normalize intracellular and extracellular K(+) balance by inhibiting IKur and reducing K(+) efflux, while the Na(+)-K(+) pump promotes K(+) influx into myofibers. Consequently, excess K(+) may be reduced from external space of myofibers. This may be a part of the Shakuyakukanzoto mechanism for improving muscle pain.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Potasio/metabolismo , Animales , Línea Celular , Combinación de Medicamentos , Glycyrrhiza/química , Ácido Glicirrínico/farmacología , Humanos , Transporte Iónico/efectos de los fármacos , Calambre Muscular/tratamiento farmacológico , Calambre Muscular/metabolismo , Fibras Musculares Esqueléticas/efectos de los fármacos , Fibras Musculares Esqueléticas/metabolismo , Paeonia , ARN Interferente Pequeño/genética , Ratas , Canales de Potasio Shab/antagonistas & inhibidores , Canales de Potasio Shab/genética , Canales de Potasio Shab/metabolismo
6.
Biol Pharm Bull ; 36(10): 1646-9, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23934345

RESUMEN

We previously demonstrated that nobiletin, a polymethoxylated flavone isolated from citrus peels, has the potential to improve cognitive dysfunction in patients with Alzheimer's disease (AD). Recent studies suggest that the generation of intraneuronal amyloid-beta (Aß) oligomers is an early event in the pathogenesis of AD. Aß oligomers cause deficits in the regulation of the extracellular signal-regulated kinase (ERK) signaling which is critical for consolidation of the memory. Our previous studies revealed that nobiletin activated ERK signaling and subsequent cyclic AMP response element-dependent transcription. In this study, the effects of five nobiletin analogs, 6-demethoxynobiletin, tangeretin, 5-demethylnobiletin, sinensetin, and 6-demethoxytangeretin, isolated from citrus peels were assessed on ERK phosphorylation in PC12D cells, and the structure-activity relationships were examined. PC12D cells were treated with nobiletin or its analogs, and the cell extracts were analyzed by Western blotting using an antibody specific to phosphorylated ERK. 6-Demethoxynobiletin markedly enhanced ERK phosphorylation in a concentration-dependent manner. These results may be useful in developing drugs and functional foods using citrus peels for the treatment of dementia including AD.


Asunto(s)
Enfermedad de Alzheimer/metabolismo , Antioxidantes/farmacología , Citrus/química , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Flavonas/farmacología , Extractos Vegetales/farmacología , Enfermedad de Alzheimer/tratamiento farmacológico , Animales , Antioxidantes/aislamiento & purificación , Antioxidantes/uso terapéutico , Western Blotting , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , Flavonas/aislamiento & purificación , Flavonas/uso terapéutico , Memoria , Células PC12 , Fosforilación , Fitoterapia , Extractos Vegetales/química , Ratas , Transducción de Señal , Relación Estructura-Actividad
7.
Drug Metab Pharmacokinet ; 28(3): 244-9, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23268924

RESUMEN

The effects of green tea catechins on the main drug-metabolizing enzymatic system, cytochrome P450 (CYP), have not been fully elucidated. The objective of the present study was to evaluate the effects of green tea extract (GTE, total catechins 86.5%, w/w) and (-)-epigallocatechin-3-gallate (EGCG) on the activities of CYP2B6, CYP2C8, CYP2C19, CYP2D6 and CYP3A in vitro, using pooled human liver and intestinal microsomes. Bupropion hydroxylation, amodiaquine N-deethylation, (S)-mephenytoin 4'-hydroxylation, dextromethorphan O-demethylation and midazolam 1'-hydroxylation were assessed in the presence or absence of various concentrations of GTE and EGCG to test their effects on CYP2B6, CYP2C8, CYP2C19, CYP2D6 and CYP3A activities, respectively. Each metabolite was quantified using UPLC/ESI-MS, and the inhibition kinetics of GTE and EGCG on CYP enzymes was analyzed. In human liver microsomes, IC50 values of GTE were 5.9, 4.5, 48.7, 25.1 and 13.8 µg/mL, for CYP2B6, CYP2C8, CYP2C19, CYP2D6 and CYP3A, respectively. ECGC also inhibited these CYP isoforms with properties similar to those of GTE, and produced competitive inhibitions against CYP2B6 and CYP2C8, and noncompetitive inhibition against CYP3A. In human intestinal microsomes, IC50 values of GTE and EGCG for CYP3A were 18.4 µg/mL and 31.1 µM, respectively. EGCG moderately inhibited CYP3A activity in a noncompetitive manner. These results suggest that green tea catechins cause clinically relevant interactions with substrates for CYP2B6 and CYP2C8 in addition to CYP3A.


Asunto(s)
Catequina/análogos & derivados , Catequina/farmacología , Inhibidores Enzimáticos del Citocromo P-450 , Extractos Vegetales/farmacología , Hidrocarburo de Aril Hidroxilasas/antagonistas & inhibidores , Citocromo P-450 CYP2B6 , Citocromo P-450 CYP2C19 , Inhibidores del Citocromo P-450 CYP2D6 , Inhibidores del Citocromo P-450 CYP3A , Sistema Enzimático del Citocromo P-450 , Humanos , Concentración 50 Inhibidora , Intestinos/citología , Cinética , Microsomas/efectos de los fármacos , Microsomas/metabolismo , Microsomas Hepáticos/efectos de los fármacos
8.
Biomed Chromatogr ; 27(1): 1-6, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22473820

RESUMEN

A rapid and quantitative analytical method for the simultaneous determination of green tea catechins using ultra-performance liquid chromatography/electrospray ionization-mass spectrometry was developed. Total analytical run time was 3.5 min for the detection of (-)-epicatechin (EC), (-)-epicatechin-3-O-gallate (ECG), (-)-epigallocatechin (EGC), (-)-epigallocatechin-3-O-gallate (EGCG) and myricetin as the internal standard (IS) in rat plasma. The calibration curves were linear over the range of 10-5000 ng/mL for all the catechins. The inter- and intra-day precision (relative standard deviation) and accuracy (percentage deviation) of the method were both lower than 10%. The average extraction recoveries in plasma ranged from 68.5 to 86.5%, and the lower limits of quantification of EC, EGC, ECG and EGCG were 10 ng/mL with a signal-to-noise ratio of >10. The assay developed was successfully applied to a pharmacokinetic study of catechins following intravenous and intragastric administrations of green tea extract in rats. Plasma concentrations of four catechins were detected up to 5-24 h after administration, and the pharmacokinetic parameters of catechins were in agreement with previous studies. From these findings, taken together with the high productivity and precision, the developed method could be a reliable and reproducible tool for the evaluation of pharmacokinetic properties of catechins.


Asunto(s)
Catequina/análogos & derivados , Catequina/sangre , Cromatografía Líquida de Alta Presión/métodos , Espectrometría de Masas en Tándem/métodos , Té/química , Animales , Catequina/química , Catequina/farmacocinética , Femenino , Ratas , Ratas Sprague-Dawley , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
9.
J Pharmacol Sci ; 108(4): 439-45, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19098391

RESUMEN

The effect of isoliquiritigenin (ISL), a component of licorice, on the voltage-dependent, ultra-rapidly activating delayed-rectifier K(+) current (IKur) was examined in H9c2 cells, a cell-line derived from rat cardiac myoblasts. IKur was recorded using the whole-cell patch clamp method with a pipette solution containing 140 mM K(+). Depolarizing voltage pulses of 200-ms duration were given with 10-mV steps every 10 s from -40 mV holding potential. ISL inhibited IKur in a concentration-dependent manner. The median inhibitory concentration (IC(50)) of ISL was approximately 0.11 microM and the Hill coefficient was 0.71. Using CHO cells expressing Kv1.5 IKur channels, ISL also inhibited Kv1.5 IKur, but less potently than the IKur current in H9c2 cells. Furthermore, in H9c2 cells, the licorice extract itself inhibited IKur in a manner similar to ISL. We conclude that ISL, one component of licorice, is a potent inhibitor of K(+) channels, which specifically in H9c2 cells could be Kv2.1, and that this inhibition may be involved in various pharmacological effects of licorice.


Asunto(s)
Chalconas/farmacología , Canales de Potasio de Tipo Rectificador Tardío/antagonistas & inhibidores , Glycyrrhiza/química , Extractos Vegetales/farmacología , Animales , Células CHO , Línea Celular , Chalconas/administración & dosificación , Chalconas/aislamiento & purificación , Cricetinae , Cricetulus , Canales de Potasio de Tipo Rectificador Tardío/metabolismo , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/administración & dosificación , Inhibidores Enzimáticos/aislamiento & purificación , Inhibidores Enzimáticos/farmacología , Concentración 50 Inhibidora , Mioblastos Cardíacos/efectos de los fármacos , Mioblastos Cardíacos/metabolismo , Técnicas de Placa-Clamp , Extractos Vegetales/administración & dosificación , Bloqueadores de los Canales de Potasio/administración & dosificación , Bloqueadores de los Canales de Potasio/aislamiento & purificación , Bloqueadores de los Canales de Potasio/farmacología , Ratas
10.
Biol Pharm Bull ; 26(12): 1661-7, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14646167

RESUMEN

The aim of this study was to assess the cardiovascular effects of a selective phosphodiesterase 5 inhibitor ER-118585, 4-[(3-chloro-4-methoxybenzyl)amino]-1-(2-hydroxy-7-azaspiro[3.5]non-7-yl)-6-phthalazinecarbonitrile monohydrochloride. The present results indicated that 1) ER-118585 significantly inhibited the human ether-a-go-go related gene (HERG) tail current at 10 nM and above with an IC(50) value of 40.7 nM in human embryonic kidney 293 cells transfected with HERG cDNA; 2) ER-118585 at 100 and 1000 nM significantly increased the action potential duration (APD) at 50% and 90% repolarization in isolated papillary muscles of guinea pig; and 3) intravenous infusion of ER-118585 at 10 microg/kg/min significantly prolonged the QT interval by 10.5+/-1.6% from 281+/-2 ms to 311+/-6 ms in six anesthetized dogs subjected to atrial pacing. In consideration of both the plasma concentration of ER-118585 (984+/-78 nM, n=3) and its protein binding fraction (99.0+/-0.1%, n=5), the free plasma concentration was estimated at 9.8+/-0.8 nM, which is consistent with the minimum concentration of HERG current inhibition. In conclusion, these evaluation methods demonstrated that ER-118585 could prolong the QT interval via APD prolongation, attributable to the inhibition of the HERG potassium current.


Asunto(s)
Evaluación Preclínica de Medicamentos , Inhibidores de Fosfodiesterasa/farmacología , Hidrolasas Diéster Fosfóricas/efectos de los fármacos , Ftalazinas/farmacología , Compuestos de Espiro/farmacología , 3',5'-GMP Cíclico Fosfodiesterasas , Potenciales de Acción/efectos de los fármacos , Potenciales de Acción/fisiología , Animales , Estimulación Cardíaca Artificial , Enfermedades Cardiovasculares/tratamiento farmacológico , Línea Celular , Fosfodiesterasas de Nucleótidos Cíclicos Tipo 5 , Perros , Relación Dosis-Respuesta a Droga , Electrocardiografía , Electrofisiología , Cobayas , Humanos , Infusiones Intravenosas , Riñón/citología , Síndrome de QT Prolongado/inducido químicamente , Síndrome de QT Prolongado/genética , Síndrome de QT Prolongado/prevención & control , Masculino , Músculos Papilares/efectos de los fármacos , Músculos Papilares/fisiología , Técnicas de Placa-Clamp , Inhibidores de Fosfodiesterasa/efectos adversos , Inhibidores de Fosfodiesterasa/sangre , Hidrolasas Diéster Fosfóricas/metabolismo , Piperidinas/farmacología , Canales de Potasio con Entrada de Voltaje/antagonistas & inhibidores , Canales de Potasio con Entrada de Voltaje/efectos de los fármacos , Canales de Potasio con Entrada de Voltaje/genética , Unión Proteica , Piridinas/farmacología , Transfección/métodos , Función Ventricular/efectos de los fármacos , Función Ventricular/genética , Función Ventricular/fisiología , Complejos Prematuros Ventriculares/tratamiento farmacológico , Complejos Prematuros Ventriculares/genética , Complejos Prematuros Ventriculares/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA